Eyenovia plans to submit for U.S. device regulatory approval in Q4 of this year, marking a key step toward ...
Eyenovia (EYEN) announces recent progress on the development of its user-filled spray dispenser. “Millions of consumers have difficulty with ...
NEW YORK – Eyenovia, Inc., a pharmaceutical company specializing in preparations, announced today a reverse stock split of its common shares in a strategic move to comply with Nasdaq's minimum bid ...
NEW YORK, Feb. 05, 2025 (GLOBE NEWSWIRE) -- Eyenovia, Inc. (NASDAQ: EYEN) (“Eyenovia” or the “Company”), an ophthalmic technology company focused on completing development of its ...
Eyenovia announces progress on its user-filled Optejet eye drop dispenser, aiming for U.S. regulatory approval in late 2025. Eyenovia, Inc. has made significant advancements in the development of ...
Eyenovia, Inc. (NASDAQ: EYEN) ("Eyenovia" or the "Company"), an ophthalmic technology company focused on completing development of its proprietary Optejet ...
Eyenovia plans to submit for U.S. device regulatory approval in Q4 of this year, marking a key step toward commercialization NEW YORK, Feb. 05, 2025 (GLOBE NEWSWIRE) -- Eyenovia, Inc. (NASDAQ: EYEN) ( ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback